Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 04 entities : Eli lilly and company save search
VistaGen Therapeutics Announces Appointment of Ann Cunningham as Chief Commercial Officer
Published: 2021-05-04 (Crawled : 12:00) - globenewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
VTGN | $4.69 0.43% 0.43% 200K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: -3.72%
commercialization
Faze Medicines Appoints Douglas Kerr, M.D., Ph.D., to its Board of Directors
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.07%
H: 1.11%
C: -0.67%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.43%
H: 0.43%
C: -0.13%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 1.72%
H: 0.31%
C: -16.76%
results report
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
ABCL | $3.92 0.0% 770K
|
|
| O: -0.65%
H: 10.38%
C: 8.4%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
covid clinical trials antibody trial covid-19
Lilly Outlines Robust Plans to Strengthen ESG Commitments Across the Globe
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
Lilly accelerating baricitinib's availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements
Published: 2021-05-04 (Crawled : 11:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
covid baricitinib therapy india merge license
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.